PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
78.38%
Growth of 78.38% while CRON.TO shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
8.67%
Cost increase while CRON.TO reduces costs. John Neff would investigate competitive disadvantage.
140.18%
Gross profit growth exceeding 1.5x CRON.TO's 13.98%. David Dodd would verify competitive advantages.
-39.19%
Margin decline while CRON.TO shows 0.00% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-40.71%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
74.54%
Marketing expense change of 74.54% while CRON.TO maintains spending. Bruce Berkowitz would investigate effectiveness.
-69.36%
Other expenses reduction while CRON.TO shows 307.55% growth. Joel Greenblatt would examine efficiency.
-3.37%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
28.01%
Total costs growth while CRON.TO reduces costs. John Neff would investigate differences.
-24.63%
Both companies reducing interest expense. Martin Whitman would check industry trends.
2.30%
D&A growth less than half of CRON.TO's 12230.06%. David Dodd would verify if efficiency is sustainable.
20.26%
EBITDA growth exceeding 1.5x CRON.TO's 11.42%. David Dodd would verify competitive advantages.
55.30%
Margin change of 55.30% while CRON.TO is flat. Bruce Berkowitz would examine quality.
12.00%
Operating income growth while CRON.TO declines. John Neff would investigate advantages.
50.67%
Margin change of 50.67% while CRON.TO is flat. Bruce Berkowitz would examine quality.
19.52%
Other expenses growth less than half of CRON.TO's 95.70%. David Dodd would verify if advantage is sustainable.
14.27%
Pre-tax income growth while CRON.TO declines. John Neff would investigate advantages.
51.94%
Margin change of 51.94% while CRON.TO is flat. Bruce Berkowitz would examine quality.
100.00%
Similar tax expense growth to CRON.TO's 98.58%. Walter Schloss would investigate patterns.
14.27%
Net income growth while CRON.TO declines. John Neff would investigate advantages.
51.94%
Margin change of 51.94% while CRON.TO is flat. Bruce Berkowitz would examine quality.
13.68%
EPS growth while CRON.TO declines. John Neff would investigate advantages.
13.68%
Diluted EPS growth while CRON.TO declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.